PI3K/Akt activation promotes tumor cell invasion by inducing MT1-MMP, implying that selective targeting and inhibition of the PI3K/Akt signaling pathway can attenuate the invasive potential of cancer cells significantly (Ispanovic and Haas, 2006). Here, MMP14 is linked to cancer.